Eagle Global Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-43,460
Closed -$342K – 385
2015
Q4
$342K Sell
43,460
-14,290
-25% -$105K 0.01% 257
2015
Q3
$331K Sell
57,750
-8,980
-13% -$55.6K 0.01% 260
2015
Q2
$361K Buy
66,730
+19,810
+42% +$102K 0.01% 262
2015
Q1
$219K Sell
46,920
-23,390
-33% -$102K 0.01% 291
2014
Q4
$293K Buy
70,310
+19,950
+40% +$91.7K 0.01% 265
2014
Q3
$262K Buy
+50,360
New +$259K 0.01% 272

Other funds holding NEO

Eagle Global Advisors's NEO Position: Q1 2016 in Review

Eagle Global Advisors sold out of NeoGenomics (NEO) in Q1 2016, closing a stake of 43,460 shares — an estimated $342K sold.

Eagle Global Advisors first reported a position in NEO in Q3 2014 and held it in 6 quarters. The position peaked at $361K in Q2 2015. 119 funds tracked by Wall St. Rank hold NEO as of Q1 2016.

  • Eagle Global Advisors reported no remaining NeoGenomics position as of Q1 2016 after selling out during the quarter.
  • Eagle Global Advisors sold 43,460 NeoGenomics shares in Q1 2016, an estimated $342K.
  • Eagle Global Advisors first reported a position in NeoGenomics in Q3 2014 and held it in 6 quarters.
  • Eagle Global Advisors's NeoGenomics position peaked at $361K in Q2 2015.
  • 119 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2016.

Based on Eagle Global Advisors's 13F filing for Q1 2016, filed 16 May 2016.